ArticleMetabolomics : Official journal of the Metabolomic Society2025
Search for new biomarkers using metabolomic analysis reflective of intestinal permeability in healthy Japanese participants.
Article in Metabolomics : Official journal of the Metabolomic Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionImproving intestinal barrier function may prevent the development of a variety of diseases. The lactulose-to-mannitol ratio (L/M) is the most widely used intestinal permeability test, but it lacks convenience and practicality.
objectivesThis study aims to validate the analysis of the relationship between L/M and metabolites in biological samples from two study populations, and to identify novel biomarkers that could increase sensitivity or simplify the detection of intestinal permeability.
methodsAfter screening 115 people for this study, plasma, urine, and fecal samples were collected from eligible participants and L/M tests were conducted. Metabolomic analysis of samples was performed using HPLC-MS/MS.
resultsData from 108 participants with available L/M test data were used for the analysis population. Participants were stratified into quartiles according to upper (positive) and lower (negative) quartile L/M test values. Candidate biomarkers of intestinal permeability was selected using comparison between two groups, partial least squares discriminant analysis (PLS-DA) and receiver operating characteristic (ROC) curves. Metabolites from plasma (n = 12), urine (n = 15), and feces (n = 36) were identified as candidate biomarkers of intestinal permeability. Data from another study comprising 149 participants was similarly analyzed, using the data from another study as the validation population. Several metabolites in plasma (n = 2), urine (n = 3), and feces (n = 3) were commonly detected in the analysis and validation populations. In feces, the predicted value using two metabolites resulted in an area under the curve of 0.853, surpassing that for a single metabolite.
conclusionsSingle or combined biological metabolites represented potential biomarkers for determining intestinal permeability. Evaluation of intestinal permeability via metabolomic analysis has utility in the early detection of diseases caused by an intestinal barrier breach.
Indexed as
Identifiers
40442511What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.